NFKB1 and COVID-19: Epigenes that participate in the immune response through different mechanisms (response to interferon or NF-kB complex) are among the main genes identified and are evident drug target candidates for COVID-19 because they already have associated drugs targeting them (such as STAT5A and STAT1).